Cutaneous plasmablastic lymphoma in an HIV-positive male: An unrecognized cutaneous manifestation

Dermatology

Volumn 208, Issue 3, 2004, Pages 287-290

  Hausermann P ^a   Khanna, N ^a   Buess, M ^a   Itin, P H ^a   Battegay, M ^a   Dirnhofer, S ^b   Buechner, S A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

AIDS related lymphoma; Cutaneous lymphomas in HIV patients; HIV associated lymphoma; Plasmablastic lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DIDANOSINE; EFAVIRENZ; LATENT MEMBRANE PROTEIN 1; PROTEIN BCL 2; PROTEIN BCL 6; SYNDECAN 1;

ADULT; B CELL LYMPHOMA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; CUTANEOUS PLASMABLASTIC LYMPHOMA; DISEASE ASSOCIATION; DISEASE COURSE; DNA DETERMINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; LABORATORY TEST; MALE; POLYMERASE CHAIN REACTION; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; SKIN BIOPSY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; HIV INFECTIONS; HUMANS; LOWER EXTREMITY; LYMPHOMA, AIDS-RELATED; MALE; MULTIPLE MYELOMA; PREDNISOLONE; SKIN NEOPLASMS; VINCRISTINE;

EID: 2342462194     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077324     Document Type: Conference Paper

References (27)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H: Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-1420.
2. Flaitz CM, Nichols CM, Walling DM, Hicks MJ: Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations. Oral Oncol 2002;38:96-102.
3. Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H: AIDS-related plasmablastic lymphomas of the oral cavity and jaws: A diagnostic dilemma. Ann Otol Rhinol Laryngol 1999;108:95-99.
4. Porter SR, Diz Dios P, Kumar N, Stock C, Barrett AW, Scally C: Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:730-734.
5. Brown RS, Campbell C, Lishman SC, Spittle MF, Miller RF: Plasmablastic lymphoma: A new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma. Clin Oncol 1998;10:327-329.
6. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001.
7. Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R: Plasmablastic lymphoma of the stomach: A case report. Haematologica 1998;83:87-89.
8. Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM: Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002;43:423-426.
9. Lin Y, Rodrigues GD, Turner JF, Vasef MA: Plasmablastic lymphoma of the lung: Report of a unique case and review of the literature. Arch Pathol Lab Med 2001;125:282-285.
10. Tulpule A, Levine A: AIDS-related lymphoma. Blood Rev 1999;13:147-150.
11. Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ: Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-1839.
12. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, et al: Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-570.
13. Ledergerber B, Telenti A, Egger M: Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. For the Swiss HIV Cohort Study. BMJ 1999;319:23-24.
14. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, Katlama C, Lazzarin A, Skinhoi P, Barton SE, EuroSIDA Study Group: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98;3406-3412.
15. Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P, Durant J, Serraino D: Reduced incidence of Kaposi's sarcoma and systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 2003;103:142-144.
16. Carbone A, Gloghini A, Capello D, Gaidano G: Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer 2001;37:1270-1275.
17. Ambinder RF: Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001;37:1209-1216.
18. Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E: Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995;2:155-166.
19. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-840.
20. Komano J, Maruo S, Kurozumi K, Oda T, Takada K: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 1999;73:9827-9831.
21. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB: Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of viral promoter usage. Virology 1992;187:189-201.
22. Tierney RJ, Steven N, Young LS, Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994;68:7374-7385.
23. Lallemand F, Fritsch L, Cywiner-Golenzer C, Rozenbaum W: Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol 1998;39:506-508.
24. Gold JE, Schwam L, Castella A, Pike SB, Opfell R, Zalusky R: Malignant plasma-cell tumors in human immunodeficieny virus-infected patients. Cancer 1990;66:363-368.
25. Kastrinakis NG, Gorgoulis VG, Foukas PG, Dimopoulos MA, Kittas C: Molecular aspects of multiple myeloma. Ann Oncol 2000;11:1217-1228.
26. Carbone A, Gloghini A, Gaidano G, Cilia AM, Bassi P, Polito P, Vacher E, Saglio G, Tirelli U: AIDS-related Burkitt's lymphoma: Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 1995;103:561-567.
27. Antinori A, Gingolani A, Alba L, Ammassari A, Serraino D, Ciancio BC, Palmieri F, De Luca A, Larocca LM, Ruco L, Ippolito G, Canda R: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483-1491.